The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 1,301–1,388 of 1,388
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Carreau, A., Battista, M., & Baillargeon, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_8 · Cited by 1
Toscano, V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_16 · Cited by 3
Belen, M. A. P. F., & Lao, S. S. (2022) · Philippine Journal of Obstetrics and Gynecology · doi:10.4103/pjog.pjog_46_22 · Cited by 1
Anebaracy, V., C, N. K., RAVI, N., et al. (2024) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2024.v17i2.48788 · Cited by 1
Glucose Intolerance in Polycystic Ovary Syndrome
Ehrmann, D. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_20 · Cited by 1
Polycystic Ovary Syndrome and Metabolic Syndrome
Pesant, M.-H., & Baillargeon, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_14 · Cited by 1
The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome
Sharma, S. T., & Nestler, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_10 · Cited by 1
Long-Term Sequelae of Polycystic Ovary Syndrome
Legro, R. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_25 · Cited by 1
Self-citationBotanical Treatment for Polycystic Ovary Syndrome
Kasim-Karakas, S. E., & Mishra, S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374228-5.00015-9 · Cited by 3
Yadav, R. P. (1970) · Nepal Journal of Obstetrics and Gynaecology · doi:10.3126/njog.v3i1.1431 · Cited by 1
The importance of screening for diabetes in women with polycystic ovary syndrome
Shorakae, S., Joham, A. E., & Teede, H. J. (2015) · Diabetes Management · doi:10.2217/dmt.14.35 · Cited by 1
Prevalence of abnormal glucose tolerance in Indian women with polycystic ovarian syndrome
Chandana, C., Nair, A. M., & Sampath, G. (2016) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20164333 · Cited by 1
Long Term Health Problems Caused by Polycystic Ovary Syndrome
Yıldızhan, B., & İlhan, G. A. (2016) · Van Medical Journal · doi:10.5505/vtd.2016.22931 · Cited by 1
Incretin System: New Pharmacological Target in Obese Women with Polycystic Ovary Syndrome
Sever, M. J., Ferjan, S., & Janež, A. (2018) · InTech eBooks · doi:10.5772/intechopen.70648 · Cited by 1
Lobo, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-65399-2.00048-6 · Cited by 1
An Overview of Harmful Effects of Polycystic Ovary Syndrome
Bilal, A. (2021) · Journal of Oncology Research Review & Reports · doi:10.47363/jonrr/2021(2)156 · Cited by 1
Polycystic Ovary Syndrome and Obstructive Sleep Apnea
Aubuchon, M. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-324-4_11 · Cited by 1
POLYCYSTIC OVARIAN SYNDROME AND EATING DISORDER: ARE THEY ASSOCIATED.
Rashmeen, S., Nisar, N., & Butt, S. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/3431 · Cited by 1
Diabetes Mellitus and Planning Conception
Singh, T. (2023) · Advances in Diabetes & Endocrinology · doi:10.13188/2475-5591.1000019
Diabetes in Special Populations
Codario, R. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-441-8_15 · Cited by 1
Marcadores precoces de doença cardiovascular em mulheres com síndrome dos ovários policísticos
Soares, G. M. (2008) · doi:10.11606/d.17.2008.tde-26092013-164044 · Cited by 1
Síndrome del ovario poliquístico: nuevas perspectivas
Pazos, F., & Rodríguez-Caballero, A. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74657-4 · Cited by 1
Type 2 Diabetes Mellitus ‒ Genetics, Diagnosis and Management. Polycystic Ovarian Syndrome
Porter, J., & Barrett, T. G. (2007) · Wiley eBooks · doi:10.1002/9780470692271.ch12 · Cited by 1
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome
Cascella, T., Palomba, S., Giallauria, F., de Sio, I., Colao, A., Lombardi, G., Orio, M., & Orio, F. (2009) · Clinical Lipidology · doi:10.2217/clp.09.55 · Cited by 1
Lifestyle Intervention in Polycystic Ovarian Syndrome
Janssen, O. E., Tan, S., & Hahn, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_28 · Cited by 1
Insulin Resistance and Insulin Secretion in the Pathophysiology of Youth Type 2 Diabetes
Bacha, F. F., & Arslanian, S. A. (2008) · CRC Press eBooks · doi:10.3109/9781420047981-10 · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Avaliação do perfil de miRNAs circulantes em pacientes com síndrome dos ovários policísticos
Maffazioli, G. D. N. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-16082021-130548 · Cited by 1
Yin, Q., Yan, X., Cao, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1301637/v1 · Cited by 1
Baillargeon, J., & Farid, N. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_18 · Cited by 2
Hassan, S., Shah, M., Malik, M. O., Ehtesham, E., Habib, H., & Rauf, B. (2022) · Research Square · doi:10.21203/rs.3.rs-1341510/v1 · Cited by 1
Joffe, H., Hall, J. E., Cohen, L. S., Taylor, A. E., & Baldessarini, R. J. (2003) · Harvard Review of Psychiatry · doi:10.1097/00023727-200303000-00005 · Cited by 1
Polycystic Ovary Syndrome Across Racial and Ethnic Groups
Engmann, L., & Legro, R. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7548-4_15
Self-citationPolycystic Ovary Syndrome and Cardiovascular Disease
nder, B., Taner, D., Ylmaz, H., & Muzaffer, M. (2012) · InTech eBooks · doi:10.5772/25519
Detection and Diagnosis of Type 2 Diabetes
Vella, A. V. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_5
Abnormal Menstrual Bleeding in Hyperandrogenic Ovulatory Dysfunction
Usadi, R. (2011) · Wiley eBooks · doi:10.1002/9781444391824.ch5
PCOS in Adolescence: Diagnostic Dilemmas and Management Considerations
Burgert, T. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_14
Haq, F., & Naru, T. Y. (2012) · InTech eBooks · doi:10.5772/21132
Síndrome de ovario poliquístico en la adolescente
Pfeifer, S. M., & Kives, S. L. (2009) · Clínicas obstétricas y ginecológicas de Norteamérica · doi:10.1016/s1885-9070(09)36008-4
Evaluation of lipid parameters and family history of diabetes mellitus in polycystic ovary syndrome
Gözükara, İ., & Gözükara, İ. (2013) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/diclemedj.0921.2013.03.0300
Metabolic Complications of Polycystic Ovary Syndrome
Setji, T. L., & Brown, A. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_23
Predictors of abnormal glucose tolerance among women with polycystic ovary syndrome
Koh, A. R., Lee, S. J., Park, S. Y., Kim, M. K., Kim, J. Y., Lee, K. W., & Kim, K. H. (2012) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2012.55.7.477
Toda, L. I., & Potau, N. (2001) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(01)74375-6
Recommandations pour le diagnostic et le suivi du syndrome des ovaires polykystiques
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Gynécologie · doi:10.1016/s0246-1064(08)44358-x
Polycystic Ovary Syndrome: Multiple Pathways to a Common Phenotype?
Coviello, A. D. (2009) · Endocrine Practice · doi:10.4158/ep09120.ed
Recomendaciones para el diagnóstico y el seguimiento del síndrome de ovarios poliquísticos
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(08)70803-8
Genética del síndrome de ovarios poliquísticos
Amato, P., & Simpson, J. L. (2006) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(06)46490-0
Metabolic syndrome: a contemporary fuel excess syndrome and its specific impact in women
Diamanti‐Kandarakis, E., & Argyrakopoulou, G. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.007
Myeloperoxidase Levels in Patients with PCOS and/or Obesity Before and After Metformin Treatment
Antoaneta, G., Kamenov, Z. A., & Tsakova, A. D. (2014) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2015.04
The Surgical Management of Polycystic Ovarian Syndrome
Davis, C. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_22
Síndrome del ovario poliquístico: ¿un camino a la diabetes mellitus?
Petermann, T. S. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74590-8
Síndrome de ovario poliquístico y enfermedad cardiovascular
Escalada, J. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)71021-4
Ovaires micropolykystiques et syndrome d’insulinorésistance
LORCY, Y. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81683-x
Genetic Analyses of Polycystic Ovary Syndrome
Urbanek, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_5
Концентрація глюкози та інсуліну у пацієнток зі синдромом полікістозних яєчників
Мілєвіч, Т., Кшисєк, Ю., Кшичковська-Сендраковська, М., et al. (2012) · Reproductive Endocrinology · doi:10.18370/2309-4117.2012.5.38-40
Appel, S. J., Massey, C. N., & Giger, J. N. (2006) · Nursing Critical Care · doi:10.1097/01244666-200607000-00009
Management of Polycystic Ovary Syndrome in the Non-Infertility Patient
Christianson, M. S., & Yates, M. M. (2011) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000397989.86605.2a
Meikle, A. W. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70199-9
Génétique du syndrome des ovaires polykystiques
Amato, P., & Simpson, J. L. (2006) · EMC - Gynécologie · doi:10.1016/s0246-1064(06)45020-9
Metabolic Aspects of Polycystic Ovary Syndrome
Svacina, S. (2015) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000471434.20331.09
Frankfurter, D. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_38
Johnston, D. G., Alberti, K. G. M. M., Godsland, I., Pierce, M. B., & Shepperd, S. (2005) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198525738.003.0043 · Cited by 13
Syndrome des ovaires polykystiques
Geyter, C. D., Strub, S., & Steinmann, S. (2008) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2008.06566
Clinical manifestations of the metabolic syndrome and type 2 diabetes in childhood and adolescence
Hamilton, J. K., & Daneman, D. (2003) · CRC Press eBooks · doi:10.3109/9780203633120-9
Reproductive endocrinology and infertility
OLSEN, M. E., & Rizk, B. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.027
Polycystic Ovary Syndrome, Insulin Resistance and Cardiovascular Disease
Corcoran, M. H., & Ehrmann, D. A. (2002) · CRC Press eBooks · doi:10.1201/b14062-10
Epidemiology of Type 2 Diabetes in Children and Adolescents
Rosenbloom, A. L. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-25
Brietzke, S. (2006) · CRC Press eBooks · doi:10.1201/b14679-9
Obesity, Polycystic Ovary Syndrome, and Mood Disorders
Reynolds-May, M. F., & Rasgon, N. (2006) · Medical psychiatry · doi:10.3109/9780849374517.009
Manonmani, D. R., & Sumithra, S. (2016) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1508063943
Role of Surgery in the Management of PCOS: Rationale and Considerations for Bariatric Surgery
Escobar-Morreale, H. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_16
Hypertension and Cardiovascular and Lipoprotein Abnormalities in the Polycystic Ovary Snydrome
Orio, F., & Palomba, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_29
Tayanloo, A., Zare, S., Karimzadeh-Bardei, L., et al. (2017) · Nova Biologica Reperta · doi:10.21859/acadpub.nbr.4.2.181
Syndrom der polyzystischen Ovarien
Geyter, C. D., Strub, S., & Steinmann, S. (2008) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2008.06566
Polycystic Ovary Syndrome and Cardiometabolic Disease
Wang, S., Navratil, A. M., & Ren, J. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00013-4
Definition criteria and diagnostic assessments
Orio, F., Volpe, A., Stasi, V. D., Savastano, S., Lombardi, G., & Colao, A. (2013) · doi:10.2217/ebo.12.194
Evaluation of the association of insulin resistance with polycystic ovary syndrome
Anuradha, V., & Bhuvaneswari, S. (2017) · International Journal of Clinical Obstetrics and Gynaecology · doi:10.33545/gynae.2017.v1.i2b.22
Limy, I., Suparman, E., & Tendean, H. M. M. (2018) · Indonesian Journal of Obstetrics and Gynecology · doi:10.32771/inajog.v6i4.849
Süt, H., Terece, C., Arınkan, S. A., et al. (2018) · Zeynep Kamil Tıp Bülteni · doi:10.16948/zktipb.468810
Avolio, M., & Ismail, H. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55138-0.00010-3
Sex Differences in Coronary Artery Disease
Kawamoto, K. R., Duvernoy, C. S., & Davis, M. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00012-9
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
